Learn More
Genscript Corporation CHO-K1/Spike Stable Cell Line
Supplier: Genscript Corporation M00803
Recombinant CHO-K1 cells stably overexpress human SARS-CoV-2 spike protein on their surface The surface expression of SARS-CoV-2 spike protein is validated by FACS analysis This stable cell line product is designed for screening antibodies against the SARS-CoV-2 spike protein as well as measuring binding affinity and stability of antibody-based biologics that bind with spike protein GenScript also offers spike protein expressing HEK293T stable cell line (Cat No M00804) for SARS-CoV-2 study
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.